Interview with the CEO: ZIOPHARM Oncology, Inc. (ZIOP)

Healthcare >> CEO Interviews >> September 22, 2014

Jonathan Lewis, M.D., Ph.D., is the Chief Executive Officer and a director of ZIOPHARM Oncology, Inc. He served as Professor of Surgery and Medicine at Memorial Sloan-Kettering Cancer Center. He has been actively involved in leading translational and clinical research in cancer. He has helped develop several drugs in cancer. He has received numerous honors and awards in medicine and science, including the ASCO Young Investigator Award, the Kristen Carr Fellowship, the Yale University Ohse Award, the Royal College of Surgeons Trubshaw Medal, and the Sarcoma Foundation of America Hope and Vision Award. He serves as a director on the board of POPPA — the Police Organization Providing Peer Assistance — of the New York Police Department, NYPD. He serves on the board of trustees for the Hope Funds for Cancer Research and serves as Board Trustee for the Kate McGarrigle Foundation. He is on the Medical Advisory Board of the Sarcoma Foundation of America and on the Scientific Advisory Board of the Combat Wound Initiative Program of the Henry Jackson Foundation for the Advancement of Military Medicine. Profile

TWST: Could you provide an overview of ZIOPHARM Oncology and talk about why the tag line of the company is: “The Future of Cancer Therapy?”

Dr. Lewis: We are a Boston-based

Join for free to read a longer excerpt or purchase this article

Interview with the CEO: ZIOPHARM Oncology, Inc. (ZIOP)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the CEO: ZIOPHARM Oncology, Inc. (ZIOP)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS